Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome
FMT appears to be cost-effective for patients with moderate-to-severe IBS who failed to respond to first-line therapy from the US payer's perspective.
Authors
- Mingjun Rui (ORCID: https://orcid.org/0000-0001-8649-6454)
- Yingcheng Wang (ORCID: https://orcid.org/0000-0002-1784-4504)
- Joyce H. S. You (ORCID: https://orcid.org/0000-0002-5763-7403)
- Qiran Wei (ORCID: https://orcid.org/0000-0002-0261-6381)
- Siew C. Ng
Institutions
- Chinese University of Hong Kong (HK)
Publication Details
- Journal
- Digestion
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1159/000549485
- Citations
- 1
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 1.40